comparemela.com

Latest Breaking News On - Genestrings diagnostic centre - Page 5 : comparemela.com

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report Firstpost 2 hours ago FP Staff © Provided by Firstpost Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report 23:36 (IST) Johnson & Johnson seeks permission for phase-3 trial in India Multinational pharma giant Johnson & Johnson has applied to India s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, PTI reported. They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

Third COVID-19 Booster Vaccine may Make Immunity Last Longer

Third COVID-19 Booster Vaccine may Make Immunity Last Longer by Colleen Fleiss on  April 19, 2021 at 11:07 PM With coronavirus variants on the rise, an annual COVID-19 vaccine or a third booster may be the key in protecting people. Since the beginning of the coronavirus pandemic in November 2019, the SARS-CoV-2 may have produced thousands of variants but most disappeared. Currently, all the vaccines require two-doses to be administered, two, three, or four weeks apart, through the intramuscular route. However, a third booster vaccine or an annual vaccine dose like other flu shots may become the normal and help immunity to last longer.

Coronavirus LIVE Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report

Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report Firstpost 2 hours ago FP Staff © Provided by Firstpost Coronavirus Updates: Johnson & Johnson seeks permission to conduct phase 3 trials in India: Report 23:36 (IST) Johnson & Johnson seeks permission for phase-3 trial in India Multinational pharma giant Johnson & Johnson has applied to India s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, PTI reported. They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

Covid symptoms | More young people testing COVID positive in second wave; displaying dry mouth, nausea, headache as symptoms

Updated Apr 18, 2021 | 16:38 IST Gauri Agarwal, chief of the Genestrings Diagnostic Centre, listed dry mouth, gastrointestinal issues, nausea, loose tools, red eyes and headache as symptoms of COVID-19 being displayed by the patients. COVID-19 testing in India  |  Photo Credit: AP New Delhi: With India continuing to register a surge in daily coronavirus cases, the head of a diagnostic firm has said that more young people as compared to old are testing positive for COVID-19 during the second wave. Gauri Agarwal, chief of the Genestrings Diagnostic Centre, said that symptoms being displayed by infected people are also different this time compared to the ones displayed during the first wave.

Upset Stomach, Conjunctivitis: What is New in India s Second Wave of Mutated Coronavirus

Upset Stomach, Conjunctivitis: What is New in India s 2nd Wave of Mutated Coronavirus | News18 Explains News18 © Provided by News18 Upset Stomach, Conjunctivitis: What is New in India s 2nd Wave of Mutated Coronavirus | News18 Explains It’s been more than a year since the deadly coronavirus wreaked havoc in India, and even after several efforts to contain the spread of it, the second wave of the virus is currently spreading like wildfire in the nation. India, which is the fourth-worst covid-hit country, currently has over 13 million cases. While the most common symptoms remain dry cough, fever, loss of taste, and smell, there has been evidence of the mutated forms of the virus producing different symptoms and reportedly being more transmissible.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.